Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pasternak

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Pharmacogenomics|July 27, 2017
Institutional profile of pharmacogenetics within University of Michigan College of PharmacyDaniel L Hertz, Jasmine A Luzum, Amy L Pasternak, et al.
Proceedings of the Clinical Dialysis and Transplant Forum|January 1, 1979
Effect of exercise on lipid metabolism and dietary intake in hemodialysis patientsM C Greene, P M Zabetakis, G W Gleim, et al.
Clinical and Translational Science|December 13, 2022
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation servicesAmy L Pasternak, Kristen Ward, Madison Irwin, et al.
Pharmacogenomics|January 7, 2021
Patients carrying DPYD variant alleles have increased risk of severe toxicity and related treatment modifications during fluoropyrimidine chemotherapyFaisal Shakeel, Fang Fang, Jung Won Kwon, et al.
Genetics|May 9, 2025
Expanding biobank pharmacogenomics through machine learning calls of structural variationBrett Vanderwerff, Amy L Pasternak, Lars G Fritsche, et al.
Pharmacogenomics|April 16, 2019
Impact of CYP3A5 phenotype on tacrolimus concentrations after sublingual and oral administration in lung transplantAmy L Pasternak, Kelley M Kidwell, Jacqueline M Dempsey, et al.
Transplantation and Cellular Therapy|September 28, 2021
Impact of Pharmacogenetics on Intravenous Tacrolimus Exposure and Conversions to Oral TherapyAmy L Pasternak, Lauren A Marcath, Yajing Li, et al.
Pharmacogenomics|December 15, 2016
The impact of the UGT1A1*60 allele on bilirubin serum concentrationsAmy L Pasternak, Kristine R Crews, Kelly E Caudle, et al.
Clinical Pharmacology and Therapeutics|May 10, 2023
Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data RepositoryAmy L Pasternak, Robinson Seda, Joseph Lipa, et al.
JCO Precision Oncology|August 25, 2020
Integration of Germline Pharmacogenetics Into a Tumor Sequencing ProgramDaniel L Hertz, Andrew Glatz, Amy L Pasternak, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Pharmacogenomics|July 27, 2017
Institutional profile of pharmacogenetics within University of Michigan College of PharmacyDaniel L Hertz, Jasmine A Luzum, Amy L Pasternak, et al.
Proceedings of the Clinical Dialysis and Transplant Forum|January 1, 1979
Effect of exercise on lipid metabolism and dietary intake in hemodialysis patientsM C Greene, P M Zabetakis, G W Gleim, et al.
Clinical and Translational Science|December 13, 2022
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation servicesAmy L Pasternak, Kristen Ward, Madison Irwin, et al.
Pharmacogenomics|January 7, 2021
Patients carrying DPYD variant alleles have increased risk of severe toxicity and related treatment modifications during fluoropyrimidine chemotherapyFaisal Shakeel, Fang Fang, Jung Won Kwon, et al.
Genetics|May 9, 2025
Expanding biobank pharmacogenomics through machine learning calls of structural variationBrett Vanderwerff, Amy L Pasternak, Lars G Fritsche, et al.
Pharmacogenomics|April 16, 2019
Impact of CYP3A5 phenotype on tacrolimus concentrations after sublingual and oral administration in lung transplantAmy L Pasternak, Kelley M Kidwell, Jacqueline M Dempsey, et al.
Transplantation and Cellular Therapy|September 28, 2021
Impact of Pharmacogenetics on Intravenous Tacrolimus Exposure and Conversions to Oral TherapyAmy L Pasternak, Lauren A Marcath, Yajing Li, et al.
Pharmacogenomics|December 15, 2016
The impact of the UGT1A1*60 allele on bilirubin serum concentrationsAmy L Pasternak, Kristine R Crews, Kelly E Caudle, et al.
Clinical Pharmacology and Therapeutics|May 10, 2023
Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data RepositoryAmy L Pasternak, Robinson Seda, Joseph Lipa, et al.
JCO Precision Oncology|August 25, 2020
Integration of Germline Pharmacogenetics Into a Tumor Sequencing ProgramDaniel L Hertz, Andrew Glatz, Amy L Pasternak, et al.
Pageof 6